Eric Greenwald focuses his practice on US patent prosecution and counseling in the biotechnology space. He has extensive knowledge in the areas of therapeutic antibodies, fusion proteins and small-molecule drugs.

Prior to joining Wolf Greenfield, Eric was an associate at Axinn, Veltrop & Harkrider LLP. There, he represented clients in patent litigation, USPTO proceedings, copyright litigation, and food and drug law. Among other responsibilities, he drafted motions, briefs, pleadings and expert declarations in district court litigations, inter partes reviews (IPRs) and interferences. 

In addition, Eric previously worked as an associate at Kenyon & Kenyon LLP representing clients in IP litigation and prosecution in the pharmaceutical and image processing fields. He drafted pleadings, discovery responses, opinions of invalidity and non-infringement, and USPTO office action responses.

Eric has a Certificate in Business Economics and Public Policy from the Wharton School at the University of Pennsylvania.
  • New York Intellectual Property Law Association: Co-Chair, Young Lawyers’ Committee and Member, Patent Litigation Committee
  • Member of New York City Bar Association Patents Committee
  • New York State Bar Association Empire State Counsel, 2017

Blogs

March 16, 2021

2020 Year in Review: Patent Decisions Impacting the Life Sciences

December 21, 2020

Economic Considerations in Granting Injunctive Relief: Federal Circuit Partially Reverses Injunctive Relief in a Case of Willful Infringement

September 23, 2020

Unqualified Antitrust Immunity: the In re Humira Decision



Scientific Publications

Ghosh, S., Greenwald, EP., (2018) Expert Q&A on Key Updates in BPCIA Litigation. Thomson Reuters Practice Law: Practice Law the Journal – Litigation. W-015-9057.


  • Guitar
  • Tennis
  • Jazz
Expand All
Eric Greenwald focuses his practice on US patent prosecution and counseling in the biotechnology space. He has extensive knowledge in the areas of therapeutic antibodies, fusion proteins and small-molecule drugs.

Prior to joining Wolf Greenfield, Eric was an associate at Axinn, Veltrop & Harkrider LLP. There, he represented clients in patent litigation, USPTO proceedings, copyright litigation, and food and drug law. Among other responsibilities, he drafted motions, briefs, pleadings and expert declarations in district court litigations, inter partes reviews (IPRs) and interferences. 

In addition, Eric previously worked as an associate at Kenyon & Kenyon LLP representing clients in IP litigation and prosecution in the pharmaceutical and image processing fields. He drafted pleadings, discovery responses, opinions of invalidity and non-infringement, and USPTO office action responses.

Eric has a Certificate in Business Economics and Public Policy from the Wharton School at the University of Pennsylvania.
  • New York Intellectual Property Law Association: Co-Chair, Young Lawyers’ Committee and Member, Patent Litigation Committee
  • Member of New York City Bar Association Patents Committee
  • New York State Bar Association Empire State Counsel, 2017

Scientific Publications

Ghosh, S., Greenwald, EP., (2018) Expert Q&A on Key Updates in BPCIA Litigation. Thomson Reuters Practice Law: Practice Law the Journal – Litigation. W-015-9057.

Blogs

March 16, 2021

2020 Year in Review: Patent Decisions Impacting the Life Sciences

December 21, 2020

Economic Considerations in Granting Injunctive Relief: Federal Circuit Partially Reverses Injunctive Relief in a Case of Willful Infringement

September 23, 2020

Unqualified Antitrust Immunity: the In re Humira Decision



  • Guitar
  • Tennis
  • Jazz